Should a contrast‑enhanced MRI of the brain be performed for the initial diagnosis of a suspected meningioma?

MRI Brain With Contrast for Initial Diagnosis of Meningioma

For the initial diagnosis of suspected meningioma, MRI brain without and with IV contrast is the imaging modality of choice and should be performed. Contrast administration is essential for optimal tumor delineation and characterization of meningiomas 1.

Why Contrast is Essential

The 2025 ACR Appropriateness Criteria explicitly states that MRI brain without and with IV contrast is a useful tool for pretreatment evaluation for suspected extraaxial brain tumor 1. The guidelines emphasize that contrast-enhanced imaging provides superior tumor delineation compared to non-contrast sequences alone 1.

Key Diagnostic Features Requiring Contrast

Meningiomas demonstrate characteristic findings on contrast-enhanced MRI that are critical for diagnosis 1:

• Homogeneous dural-based enhancement - the hallmark feature
• Dural tail sign - tapering extension along adjacent dura mater
• CSF cleft between tumor and brain parenchyma
• Intratumoral calcifications (visualized with SWI sequences)

Evidence Supporting Contrast Enhancement

Historical research demonstrates that contrast-enhanced studies are superior to plain MRI for both image contrast and tumor delineation. In a comparative study, adequate tumor delineation was achieved in only 35 cases with plain MRI versus 50 cases with contrast-enhanced MRI 2. Contrast-enhanced T1-weighted images have proven particularly valuable in distinguishing benign from nonbenign meningiomas based on enhancement patterns 3.

Clinical Algorithm

1. Order MRI brain without and with IV contrast as the initial study
2. Include standard sequences: high-resolution 3D T1 pre- and post-contrast, T2 FLAIR, diffusion-weighted imaging, and SWI 1
3. Evaluate for characteristic meningioma features on post-contrast images
4. Assess for atypical features suggesting meningioma mimics or higher-grade tumors

Important Caveats

Red flags on imaging that suggest alternative diagnoses or higher-grade tumors 1:

• Marked T2-hypo- or hyperintensity
• Absence of dural tail
• Dural displacement sign (rather than dural attachment)
• Markedly irregular tumor margins
• Irregular nodules or mushrooming pattern
• Markedly inhomogeneous enhancement

These findings warrant heightened suspicion for either meningioma mimics or atypical/malignant meningiomas.

Contrast Necessity

While some recent research suggests T2-weighted imaging alone may detect tumor growth during surveillance 4, this does not apply to initial diagnosis where contrast is mandatory for proper characterization. The EANO guidelines confirm that provisional diagnosis is made by neuroimaging, with MRI being the standard 5, and the ACR guidelines make clear this requires contrast administration for extraaxial tumors like meningiomas 1.

Advanced imaging techniques (perfusion MRI, MR spectroscopy) may serve as adjunct tools, particularly for grading purposes, but are not required for initial diagnosis 1, 6.